RxDoctor Payments Data

Glory Yorke

Medical · Las Vegas, NVNPI 1447569363

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,993 of the $6,883 with a category attached, or 87.1%. 18 manufacturers reported payments, led by AstraZeneca at 27.9% of the total.

$6,883in general payments, 2019–2025

Across 236 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Biohaven Pharmaceuticals, Inc.$835
  • AbbVie$548
  • Amgen$520
  • Bayer$413
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$80012%
  • Food & beverage$5,99387%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,883 in reported general payments places this provider in the 85th percentile of 250 medical providers in Nevada.

See all medical providers in Nevada

Other medical in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →